The Medicines Company (MDCO) PT Raised to $51 at BofA/Merrill Lynch
Tweet Send to a Friend
BofA/Merrill Lynch analyst Tazeen Ahmad raised the price target on The Medicines Company (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


